merylg
Senior Member
- Messages
- 841
- Location
- Sydney, NSW, Australia
-
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
MND, ALS... HERVs... ARVs...
- Thread starter merylg
- Start date
merylg
Senior Member
- Messages
- 841
- Location
- Sydney, NSW, Australia
"The Lighthouse Project is the first Phase 2 clinical trial in the world to use modern combination anti-retroviral therapy in patients with MND. The study aims to determine the safety and tolerability of an anti-retroviral therapy “Triumeq” and provide preliminary data on whether it is able to slow down the progression of MND. Triumeq is already used to treat HIV infection safely and effectively. "
and
"The Lighthouse Project is supported by the Motor Neurone Disease Research Institute of Australia and the Cure for MND Foundation."
and
"The Lighthouse Project is supported by the Motor Neurone Disease Research Institute of Australia and the Cure for MND Foundation."